Another scenario that would likely be encountered in clinical practice by the general physician is the elevation of NT-proBNP with the current guideline recommended cut of point of 125, this biomarker suggests not only underlying heart failure but also the presence of elevated cardiovascular risk. The gene discussed is NPPB; the disease is heart failure.